Literature DB >> 26481549

Serum concentrations of chemokines (CCL-5 and CXCL-12), chemokine receptors (CCR-5 and CXCR-4), and IL-6 in patients with posttraumatic stress disorder and avoidant personality disorder.

Ewa A Ogłodek1, Anna M Szota2, Danuta M Moś3, Aleksander Araszkiewicz2, Adam R Szromek4.   

Abstract

BACKGROUND: Posttraumatic stress disorder (PTSD) can be perceived as a psychoneuroimmunological disorder in which cytokines affecting the neurochemical and neuroendocrine functions of the body play an important role. Among cytokines, chemokines participating in activation of the inflammatory response are considered to be crucial.
METHOD: 220 men and women were enrolled in the study. 180 of them constituted the study group. The studied groups consisted of: 60 patients with a diagnosed avoidant personality disorders (APD), 60 patients with a diagnosed APD and with PTSD and of 60 patients with PTSD but without a APD. There were 30 women and 30 men in each group of 60 subjects. The control group consisted of 40 healthy individuals. The plasma levels of chemokines and their receptors (CCL-5, CXCR-5, CXCL-12 and CXCR-4), as well as IL-6, were assessed by ELISA.
RESULTS: There was an increase in the CXCL-12 and CCL-5 levels in women and men with the PTSD versus the control group. Also, increased levels of IL-6 and the receptors CXCR-4, CCR-5 were observed in women and men with PTSD. The levels of CXCL-12 and CCL-5 chemokines, as well as CCR-5 and CXCR4 receptors were higher in women than in men. The results of this study indicate a need for assessment of the CCL-5 and CXCL-12 chemokine levels, as they are likely markers of PTSD.
CONCLUSIONS: Measurement of the concentrations of chemokines, chemokine receptors and IL-6 in women and men with PTSD along with concomittant APD may be useful for early detection of mental disorders.
Copyright © 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Chemokines; Personality disorders; Posttraumatic stress disorder

Mesh:

Substances:

Year:  2015        PMID: 26481549     DOI: 10.1016/j.pharep.2015.05.023

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  5 in total

1.  Synthesis and evaluation of an (18)F-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in gliomas.

Authors:  Dustin Wayne Demoin; Masahiro Shindo; Hanwen Zhang; Kimberly J Edwards; Inna Serganova; Naga Vara Kishore Pillarsetty; Jason S Lewis; Ronald G Blasberg
Journal:  Nucl Med Biol       Date:  2016-05-14       Impact factor: 2.408

2.  Chemokine (C-C motif) ligand 5 (RANTES) concentrations in the peripheral blood of patients with a depressive disorder.

Authors:  Elżbieta Małujło-Balcerska; Anna Kumor-Kisielewska; Janusz Szemraj; Tadeusz Pietras
Journal:  Pharmacol Rep       Date:  2022-03-16       Impact factor: 3.919

3.  Hematogenous Dissemination of Mesenchymal Stem Cells from Endometriosis.

Authors:  Fei Li; Myles H Alderman; Aya Tal; Ramanaiah Mamillapalli; Alexis Coolidge; Demetra Hufnagel; Zhihao Wang; Elham Neisani; Stephanie Gidicsin; Graciela Krikun; Hugh S Taylor
Journal:  Stem Cells       Date:  2018-03-01       Impact factor: 6.277

4.  Regulated upon activation, normal T cell expressed and secreted (RANTES) levels in the peripheral blood of patients with Alzheimer's disease.

Authors:  Gabriela Vacinova; Daniela Vejražkova; Robert Rusina; Iva Holmerová; Hana Vaňková; Eva Jarolímová; Josef Včelák; Běla Bendlová; Markéta Vaňková
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

5.  Potential chemokine biomarkers associated with PTSD onset, risk and resilience as well as stress responses in US military service members.

Authors:  Lei Zhang; Xian-Zhang Hu; Robert J Ursano; Xiaoxia Li; Ze Chen; David M Benedek; Carol S Fullerton; Gary Wynn
Journal:  Transl Psychiatry       Date:  2020-01-23       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.